Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study).

Pels A, Mol BWJ, Singer J, Lee T, von Dadelszen P, Ganzevoort W, Asztalos E, Magee LA; CHIPS Study Group.

Hypertension. 2018 Jun;71(6):1170-1177. doi: 10.1161/HYPERTENSIONAHA.117.10689. Epub 2018 Apr 23.

2.

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J; IBIS-II investigators.

Lancet. 2016 Feb 27;387(10021):866-73. doi: 10.1016/S0140-6736(15)01129-0. Epub 2015 Dec 11.

3.

Tracking Parkinson's: Study Design and Baseline Patient Data.

Malek N, Swallow DM, Grosset KA, Lawton MA, Marrinan SL, Lehn AC, Bresner C, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG; PRoBaND.

J Parkinsons Dis. 2015;5(4):947-59. doi: 10.3233/JPD-150662.

4.

Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery.

Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM; ERICCA Trial Investigators.

N Engl J Med. 2015 Oct 8;373(15):1408-17. doi: 10.1056/NEJMoa1413534. Epub 2015 Oct 5.

5.

High strain rate testing of bovine trabecular bone.

Pilcher A, Wang X, Kaltz Z, Garrison JG, Niebur GL, Mason J, Song B, Cheng M, Chen W.

J Biomech Eng. 2010 Aug;132(8):081012. doi: 10.1115/1.4000086.

PMID:
20670061
6.

Patterns of resistance to exonuclease digestion of oligonucleotides containing polycyclic aromatic hydrocarbon diol epoxide adducts at N6 of deoxyadenosine.

Ilankumaran P, Pannell LK, Gebreselassie P, Pilcher AS, Yagi H, Sayer JM, Jerina DM.

Chem Res Toxicol. 2001 Sep;14(9):1330-8.

PMID:
11559050
7.
8.

Factors determining mutagenic potential for individual cis and trans opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts.

Pontén I, Sayer JM, Pilcher AS, Yagi H, Kumar S, Jerina DM, Dipple A.

Biochemistry. 2000 Apr 11;39(14):4136-44.

PMID:
10747805
9.

Mutational consequences of replication of M13mp7L2 constructs containing cis-opened benzo[a]pyrene 7,8-diol 9, 10-epoxide-deoxyadenosine adducts.

Page JE, Pilcher AS, Yagi H, Sayer JM, Jerina DM, Dipple A.

Chem Res Toxicol. 1999 Mar;12(3):258-63.

PMID:
10077488
10.

Sequence context effects on mutational properties of cis-opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts in site-specific mutation studies.

Pontén I, Sayer JM, Pilcher AS, Yagi H, Kumar S, Jerina DM, Dipple A.

Biochemistry. 1999 Jan 19;38(3):1144-52.

PMID:
9894012
11.

Supplemental Content

Loading ...
Support Center